PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...
For the past year, the pharmaceutical industry has wrestled with Washington, as President Donald Trump has demanded that drug companies cut their prices or face his wrath — including the threat of ...
Stevanato Group (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology ...
Crain's New York: City pharmaceutical stocks remain stable as industry-wide tariffs move forward
The city’s pharmaceutical industry remained stable on Tuesday as federal officials signaled that tariffs could be around the corner. The federal government filed a federal notice on Monday announcing ...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, ...
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group ...
Yahoo Finance: $7.82 Bn Pharmaceutical Isolators Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
$7.82 Bn Pharmaceutical Isolators Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
Morningstar: Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company
Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company